Regfo
PrivateLast Round
Pre Seed
May 1, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Regfo is a biotechnology software company that provides an AI-powered regulatory compliance platform for drug and biologic IND readiness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, RegTech, Compliance & Risk, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regfo Comparables
Compare Regfo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tehistark OÜ | 78% | |
| Weave Bio | 76% | |
| E-Biotech Inc. | 64% | |
Regfo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 1, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors grew 615% MoM, from 255 to 1.8K.
Regfo Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Regfo's valuation, stock price, and market status.